0001209191-22-009417.txt : 20220214 0001209191-22-009417.hdr.sgml : 20220214 20220214172817 ACCESSION NUMBER: 0001209191-22-009417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jakobovits Aya CENTRAL INDEX KEY: 0001823901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 22635193 MAIL ADDRESS: STREET 1: 3135 HUTTON DRIVE CITY: BEVERLY HILLS STATE: CA ZIP: 90210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET STREET 2: FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET STREET 2: FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-03 0 0001720580 Adicet Bio, Inc. ACET 0001823901 Jakobovits Aya C/O ADICET BIO, INC. 200 CLARENDON STREET, FLOOR 6 BOSTON MA 02116 1 0 0 0 Common Stock 2022-01-03 4 S 0 6000 18.0208 D 366343 I See Footnote Common Stock 2022-01-03 4 S 0 6000 18.0218 D 366345 I See Footnote Common Stock 2022-01-05 4 S 0 2000 16.932 D 364343 I See Footnote Common Stock 2022-01-05 4 S 0 2000 16.8995 D 364345 I See Footnote Common Stock 2022-02-09 4 S 0 4000 14.0294 D 360343 I See Footnote Common Stock 2022-02-09 4 S 0 4000 14.0303 D 360345 I See Footnote Common Stock 138076 I See Footnote These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees. /s/ Nick Harvey, Attorney-in-Fact for Aya Jakobovits 2022-02-14